Rossi Ljubomir, Kadamba Padmalatha, Hugosson Claes, De Vol Edward B, Habib Zakaria, Al-Nassar Saleh
Department of Pediatric Surgery, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
J Pediatr Gastroenterol Nutr. 2007 Aug;45(2):213-21. doi: 10.1097/MPG.0b013e31803c75e8.
Short bowel syndrome (SBS) develops after massive small bowel resections. Patients with less than 12 cm of jejunoileum have a slim possibility of being weaned from parenteral nutrition (PN).
In a retrospective review of records of consecutive patients with SBS, 8 patients were evaluated for treatment by adaptation and weaning from PN. These included 4 patients with class I SBS (0-10 cm of small bowel), one with class II SBS (>10-25 cm), one with class III SBS (>25-50 cm), and 2 with class IV SBS (>50-75 cm). Adaptation was assessed by measuring growth in the small bowel and the ability to be weaned from PN.
Adaptation was achieved primarily by extending the length of jejunoileum by approximately 450% over the first 2.5 years after resection and by increasing the degree of colonic fermentation and absorption of nutrients. As of July 1, 2005, all of the patients were off PN, with the exception of 2 patients with class I-A SBS: patient 3 had a remaining jejunoileum of only 2.5 cm and patient 4 had a remaining jejunoileum of 9 cm but developed eosinophilic enterocolitis. These 2 patients continued with PN on alternate months.
Bowel growth after massive small bowel resection provides an objective parameter of adaptation and a means of predicting ability to be weaned from PN. Aggressive nutritional support makes even patients with class I SBS, whose disease was previously considered hopeless, likely candidates to achieve freedom from PN.
短肠综合征(SBS)在大量小肠切除术后发生。空回肠长度不足12 cm的患者停用肠外营养(PN)的可能性很小。
在一项对连续性SBS患者记录的回顾性研究中,评估了8例患者通过适应性调整和停用PN进行治疗的情况。其中包括4例I类SBS患者(小肠长度0 - 10 cm),1例II类SBS患者(> 10 - 25 cm),1例III类SBS患者(> 25 - 50 cm),以及2例IV类SBS患者(> 50 - 75 cm)。通过测量小肠生长情况以及停用PN的能力来评估适应性。
适应性主要通过在切除术后的最初2.5年内将空回肠长度延长约450%,以及增加结肠发酵和营养物质吸收程度来实现。截至2005年7月1日,除2例I - A类SBS患者外,所有患者均已停用PN:3号患者剩余空回肠仅2.5 cm,4号患者剩余空回肠9 cm,但发生了嗜酸性粒细胞性小肠结肠炎。这2例患者每隔一个月继续接受PN治疗。
大量小肠切除术后的肠生长提供了适应性的客观参数以及预测停用PN能力的手段。积极的营养支持使即使是以前被认为无药可救的I类SBS患者也有可能停用PN。